Acutus Medical, Inc. (AFIB)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
David H. Roman
Employees:
340
2210 FARADAY AVE, SUITE 100, CARLSBAD, CA 92008
442-232-6080

Acutus Medical, Inc. designs, manufactures, and markets a range of tools for catheter-based ablation procedures. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, and mapping and imaging consoles and accessories.

Data derived from most recent annual or quarterly report
Market Cap 23.046 Million Shares Outstanding28.452 Million Avg 30-day Volume 136.847 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.72
Price to Revenue1.5832 Debt to Equity0.5938 EBITDA-65.257 Million
Price to Book Value0.4319 Operating Margin-469.85349999999994 Enterprise Value-7.186 Million
Current Ratio5.125 EPS Growth-1.064 Quick Ratio3.794
1 Yr BETA 1.0439 52-week High/Low 2.15 / 0.48 Profit Margin-545.5053
Operating Cash Flow Growth6.5177 Altman Z-Score-7.4551 Free Cash Flow to Firm -38.418 Million
Earnings Report2023-05-11
View SEC Filings from AFIB instead.

View recent insider trading info

Acutus Medical, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding AFIB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AFIB

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-03-02 by SOHN TOM
  • 4: filed on 2023-03-02 by MATHEWS KEVIN
  • 4: filed on 2023-03-02 by ROMAN DAVID
  • 4: filed on 2023-03-02 by MUKAI TAKEO
  • 4: filed on 2023-03-02 by PISCITELLO CHARLIE
  • 4: filed on 2023-02-02 by MUKAI TAKEO
  • 4: filed on 2023-02-02 by ROMAN DAVID
  • 4: filed on 2023-02-02 by PISCITELLO CHARLIE
  • 4: filed on 2023-02-02 by MATHEWS KEVIN
  • 4: filed on 2023-02-02 by SOHN TOM

    • Events (8k)

  • 8-K: filed on 2023-03-16:
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-13:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-10:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-05:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-04:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2022-11-03:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-22:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2022-08-11:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SOHN TOM SVP, GEN. COUNSEL & SECRETARY

    • Officer
    		 99,588 2023-03-01 5

    PISCITELLO CHARLIE SVP, CHIEF PEOPLE OFFICER

    • Officer
    		 86,538 2023-03-01 5

    ROMAN DAVID PRESIDENT & CEO

    • Officer
    		 383,159 2023-03-01 5

    MATHEWS KEVIN SVP, COMMERCIAL

    • Officer
    		 66,653 2023-03-01 5

    MUKAI TAKEO CFO

    • Officer
    		 83,948 2023-03-01 4

    HUENNEKENS R SCOTT

    • Director
    		 518,429 2022-10-01 3

    GARLAND JASON K

    • Director
    		 46,500 2022-09-01 2

    FLYNN JAMES E

    DEERFIELD MGMT L.P.

    DEERFIELD MGMT III, L.P.

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD PARTNERS, L.P.

    DEERFIELD PRIVATE DESIGN FUND III, L.P.

    • Director
    • 10% Owner
    • DIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATION
    		 5,415,449 2022-06-30 1

    SHERIDAN JOHN F

    • Director
    		 35,547 2022-06-16 1

    HINRICHS JAMES F.

    • Director
    		 76,310 2022-06-16 1

    CRAMP DANIELLA

    • Director
    		 31,223 2022-06-16 1

    BONITA DAVID P

    • Director
    • 10% Owner
    		 1,709,383 2022-06-16 1

    PELLEGRINI NIAMH LOUISE

    • Director
    		 32,172 2022-06-16 1

    ELBARDISSI ANDREW

    • Director
    		 32,022 2022-06-16 1

    MARZOUK SHADEN

    • Director
    		 32,022 2022-06-16 1

    BURGESS VINCENT J CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 61,469 2022-04-01 1

    MCQUILLAN STEVEN SVP, CLINICAL AFFAIRS & QA

    • Officer
    		 45,844 2022-04-01 1

    ORBIMED ADVISORS LLC

    ORBIMED CAPITAL GP IV LLC

    ORBIMED ROF II LLC

    • Director
    • 10% Owner
    		 6,553,408 2021-07-19 0

    FLYNN JAMES E

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    • Director
    • 10% Owner
    • DIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATION
    		 4,022 2021-06-17 1

    MALIK SHAHZAD

    • Director
    		 1,628,193 2021-06-17 0

    BARNICKEL JOHN CHIEF COMMERCIAL OFFICER

    • Officer
    		 13,966 2020-08-10 0

    DOHERTY GARY W. CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2020-08-05 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    MATHEWS KEVIN - Officer SVP, COMMERCIAL

    		2023-03-02 16:47:31 -0500 2023-03-01 A 42,500 a 66,653 direct 1.6667 -23.3333 1.6667 2 -23.3333 6

    MATHEWS KEVIN - Officer SVP, COMMERCIAL

    		2023-03-02 16:47:31 -0500 2023-03-01 A 42,500 a 42,500 direct

    MUKAI TAKEO - Officer CFO

    		2023-03-02 16:46:21 -0500 2023-03-01 A 47,500 a 83,948 direct 1.6667 -23.3333 1.6667 2 -23.3333 6

    MUKAI TAKEO - Officer CFO

    		2023-03-02 16:46:21 -0500 2023-03-01 A 47,500 a 47,500 direct

    PISCITELLO CHARLIE - Officer SVP, CHIEF PEOPLE OFFICER

    		2023-03-02 16:45:55 -0500 2023-03-01 A 42,500 a 86,538 direct 1.6667 -23.3333 1.6667 2 -23.3333 6

    PISCITELLO CHARLIE - Officer SVP, CHIEF PEOPLE OFFICER

    		2023-03-02 16:45:55 -0500 2023-03-01 A 42,500 a 42,500 direct

    ROMAN DAVID - Officer PRESIDENT & CEO

    		2023-03-02 16:47:00 -0500 2023-03-01 A 135,000 a 383,159 direct 1.6667 -23.3333 1.6667 2 -23.3333 6

    ROMAN DAVID - Officer PRESIDENT & CEO

    		2023-03-02 16:47:00 -0500 2023-03-01 A 135,000 a 135,000 direct

    SOHN TOM - Officer SVP, GEN. COUNSEL & SECRETARY

    		2023-03-02 16:48:06 -0500 2023-03-01 A 42,500 a 99,588 direct 1.6667 -23.3333 1.6667 2 -23.3333 6

    SOHN TOM - Officer SVP, GEN. COUNSEL & SECRETARY

    		2023-03-02 16:48:06 -0500 2023-03-01 A 42,500 a 42,500 direct

    MUKAI TAKEO - Officer CFO

    		2023-02-02 17:10:08 -0500 2023-02-01 F 2,855 $1.87 d 36,448 direct 3.9106 -15.0838 -54.7486 3.9106 2 -54.7486 31

    ROMAN DAVID - Officer PRESIDENT & CEO

    		2023-02-02 17:09:38 -0500 2023-02-01 F 10,196 $1.87 d 248,159 direct 3.9106 -15.0838 -54.7486 3.9106 2 -54.7486 31

    PISCITELLO CHARLIE - Officer SVP, CHIEF PEOPLE OFFICER

    		2023-02-02 17:09:12 -0500 2023-02-01 F 6,627 $1.87 d 44,038 direct 3.9106 -15.0838 -54.7486 3.9106 2 -54.7486 31

    MATHEWS KEVIN - Officer SVP, COMMERCIAL

    		2023-02-02 17:08:55 -0500 2023-02-01 F 3,540 $1.87 d 24,153 direct 3.9106 -15.0838 -54.7486 3.9106 2 -54.7486 31

    SOHN TOM - Officer SVP, GEN. COUNSEL & SECRETARY

    		2023-02-02 17:08:36 -0500 2023-02-01 F 6,525 $1.87 d 57,190 direct 3.9106 -15.0838 -54.7486 3.9106 2 -54.7486 31

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ACUTUS MEDICAL INC AFIB 2023-03-24 17:45:03 UTC -3.9474 8.7674 200000
    ACUTUS MEDICAL INC AFIB 2023-03-24 17:15:03 UTC -3.9474 8.7674 200000
    ACUTUS MEDICAL INC AFIB 2023-03-24 16:45:03 UTC -3.8943 8.7143 200000
    ACUTUS MEDICAL INC AFIB 2023-03-24 16:15:03 UTC -3.8943 8.7143 200000
    ACUTUS MEDICAL INC AFIB 2023-03-24 15:45:03 UTC -3.8943 8.7143 200000
    ACUTUS MEDICAL INC AFIB 2023-03-24 15:15:03 UTC -3.8943 8.7143 200000
    ACUTUS MEDICAL INC AFIB 2023-03-24 14:45:03 UTC -3.8943 8.7143 200000
    ACUTUS MEDICAL INC AFIB 2023-03-24 14:15:03 UTC -3.8943 8.7143 200000
    ACUTUS MEDICAL INC AFIB 2023-03-24 13:45:03 UTC -4.3984 8.9684 200000
    ACUTUS MEDICAL INC AFIB 2023-03-24 13:15:04 UTC -4.3984 8.9684 200000
    ACUTUS MEDICAL INC AFIB 2023-03-24 12:45:03 UTC -4.3984 8.9684 750000
    ACUTUS MEDICAL INC AFIB 2023-03-23 22:15:04 UTC -4.3984 8.9684 750000
    ACUTUS MEDICAL INC AFIB 2023-03-23 21:45:04 UTC -4.3984 8.9684 750000
    ACUTUS MEDICAL INC AFIB 2023-03-23 21:15:04 UTC -4.3984 8.9684 750000
    ACUTUS MEDICAL INC AFIB 2023-03-23 20:45:03 UTC -4.3984 8.9684 750000
    ACUTUS MEDICAL INC AFIB 2023-03-23 20:15:03 UTC -4.3984 8.9684 750000
    ACUTUS MEDICAL INC AFIB 2023-03-23 19:45:03 UTC -4.3984 8.9684 750000
    ACUTUS MEDICAL INC AFIB 2023-03-23 19:15:03 UTC -4.3984 8.9684 750000
    ACUTUS MEDICAL INC AFIB 2023-03-23 18:45:04 UTC -4.3984 8.9684 750000
    ACUTUS MEDICAL INC AFIB 2023-03-23 18:15:03 UTC -4.3984 8.9684 750000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Prudential Investment Portfolios 12- PGIM QMA Large-Cap Core Equity Plus Fund AFIB -900.0 shares, $-15282.0 2021-06-30 N-PORT
    Prudential Investment Portfolios 12- PGIM QMA Long-Short Equity Fund AFIB -1900.0 shares, $-16796.0 2021-09-30 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund AFIB -7000.0 shares, $-8050.0 2022-12-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments